Proton beam therapy in repeat irradiation of recurrent head and neck tumors: analysis of short-term results

D. Smyk, I. Gulidov, K. Gordon, D. Gogolin, S. S. Dyuzhenko, A. V. Semenov
{"title":"Proton beam therapy in repeat irradiation of recurrent head and neck tumors: analysis of short-term results","authors":"D. Smyk, I. Gulidov, K. Gordon, D. Gogolin, S. S. Dyuzhenko, A. V. Semenov","doi":"10.17650/2222-1468-2022-12-4-39-47","DOIUrl":null,"url":null,"abstract":"Introduction. Recurrence of head and neck tumors occurs in 50 % of cases and usually has locoregional character. Due to the characteristics of dose distribution, proton beam therapy is a promising treatment option for patients with recurrences of tumors in this location who previously underwent radiation therapy.Aim. To evaluate the effectiveness and tolerability of repeat irradiation using active scanning proton beam therapy in patients with recurrent head and neck tumors who previously underwent radiation therapy.Materials and methods. Between November of 2015 and December of 2020, 40 patients with locoregional recurrence of head and neck tumors underwent treatment using active scanning proton beam therapy at the A. F . Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center. Median cumulative dose of primary irradiation was 64.5 Gy. Median time between primary and repeat irradiation was 35.7 months, mean irradiated volume of the repeat course was 94.5 cm3. Proton beam therapy was performed using standard mode (2 isoGy) and accelerated hypofractionation (2.4 isoGy / 3 isoGy) with mean equivalent cumulative dose of 56.4 Gy (α / β = 10). Radiation toxicity was evaluated using the Radiation Therapy Oncology Group European (RTOG) / Organization for Research and Treatment of Cancer (EORTC) scale.Results. Treatment response was achieved in 34 (85 %) patients: in 17 (42.5 %) patients, stable disease was observed; in 10 (25 %) patients, partial response was observed; and in 7 (17.5 %) patients, complete response was observed. In 6 (15 %) cases, disease progression was diagnosed at first follow-up examination. One- and two-year locoregional control, progression-free survival and overall survival were 58.4 / 19.8; 44.5 / 19.8 and 82.3 / 38.8 % respectively with median follow-up duration of 14.2 months. Median survival was 19.5 months. Grade III and above early radiation toxicity was observed in 3 (7.5 %) patients. In total, 6 (15 %) cases of grade III complications and 2 (5 %) episodes of carotid artery rupture leading to death were observed. Overall frequency of complications of grade III and higher was 20 %.Conclusion. Repeat irradiation using proton beam therapy can be considered an effective and safe treatment method for patients with recurrent head and neck tumors. Dosimetric and radiobiological benefits of proton beams allow to achieve balance between high doses and radiation exposure in previously irradiated tissues.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and neck tumors (HNT)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2222-1468-2022-12-4-39-47","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Recurrence of head and neck tumors occurs in 50 % of cases and usually has locoregional character. Due to the characteristics of dose distribution, proton beam therapy is a promising treatment option for patients with recurrences of tumors in this location who previously underwent radiation therapy.Aim. To evaluate the effectiveness and tolerability of repeat irradiation using active scanning proton beam therapy in patients with recurrent head and neck tumors who previously underwent radiation therapy.Materials and methods. Between November of 2015 and December of 2020, 40 patients with locoregional recurrence of head and neck tumors underwent treatment using active scanning proton beam therapy at the A. F . Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center. Median cumulative dose of primary irradiation was 64.5 Gy. Median time between primary and repeat irradiation was 35.7 months, mean irradiated volume of the repeat course was 94.5 cm3. Proton beam therapy was performed using standard mode (2 isoGy) and accelerated hypofractionation (2.4 isoGy / 3 isoGy) with mean equivalent cumulative dose of 56.4 Gy (α / β = 10). Radiation toxicity was evaluated using the Radiation Therapy Oncology Group European (RTOG) / Organization for Research and Treatment of Cancer (EORTC) scale.Results. Treatment response was achieved in 34 (85 %) patients: in 17 (42.5 %) patients, stable disease was observed; in 10 (25 %) patients, partial response was observed; and in 7 (17.5 %) patients, complete response was observed. In 6 (15 %) cases, disease progression was diagnosed at first follow-up examination. One- and two-year locoregional control, progression-free survival and overall survival were 58.4 / 19.8; 44.5 / 19.8 and 82.3 / 38.8 % respectively with median follow-up duration of 14.2 months. Median survival was 19.5 months. Grade III and above early radiation toxicity was observed in 3 (7.5 %) patients. In total, 6 (15 %) cases of grade III complications and 2 (5 %) episodes of carotid artery rupture leading to death were observed. Overall frequency of complications of grade III and higher was 20 %.Conclusion. Repeat irradiation using proton beam therapy can be considered an effective and safe treatment method for patients with recurrent head and neck tumors. Dosimetric and radiobiological benefits of proton beams allow to achieve balance between high doses and radiation exposure in previously irradiated tissues.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
质子束治疗复发性头颈部肿瘤重复照射的近期效果分析
介绍。头颈部肿瘤的复发率为50%,通常具有局部性。由于剂量分布的特点,质子束治疗是一种很有前途的治疗选择肿瘤复发的这一部位,以前接受过放疗。评价主动扫描质子束治疗头颈部肿瘤复发患者放射治疗的有效性和耐受性。材料和方法。2015年11月至2020年12月,40例头颈部肿瘤局部复发患者在a - F接受了主动扫描质子束治疗。医学放射研究中心-国家医学放射研究中心的分支机构。初次照射的中位累积剂量为64.5 Gy。第一次和重复放疗的中位时间为35.7个月,重复疗程的平均放疗体积为94.5 cm3。采用标准模式(2 isoGy)和加速减分(2.4 isoGy / 3 isoGy)进行质子束治疗,平均等效累积剂量为56.4 Gy (α / β = 10)。放射毒性采用欧洲肿瘤放射治疗组织(RTOG) /癌症研究与治疗组织(EORTC)标准进行评估。34例(85%)患者获得治疗缓解,17例(42.5%)患者病情稳定;在10例(25%)患者中观察到部分缓解;7例(17.5%)患者完全缓解。在6例(15%)病例中,疾病进展在第一次随访检查中被诊断出来。1年和2年局部区域对照、无进展生存期和总生存期分别为58.4 / 19.8;分别为44.5 / 19.8%和82.3 / 38.8%,中位随访时间14.2个月。中位生存期为19.5个月。3例(7.5%)患者出现III级及以上早期放射毒性。总共观察到6例(15%)III级并发症和2例(5%)颈动脉破裂导致死亡。III级及以上并发症的总发生率为20%。使用质子束重复照射治疗头颈部肿瘤复发是一种安全有效的治疗方法。质子束的剂量学和放射生物学益处允许在高剂量和先前照射组织的辐射暴露之间实现平衡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The importance in clinical practice of the signal lymph node biopsy in squamous cell carcinoma of the head and neck From the history of development of departments of medical service for head and neck tumors “Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use Low expression of the ST6GAL2 and CD248 genes as an unfavorable prognostic marker of oral squamous cell carcinoma Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1